US Stock MarketDetailed Quotes

ALLO Allogene Therapeutics

Watchlist
  • 2.845
  • +0.015+0.53%
Trading Jul 22 15:02 ET
593.99MMarket Cap-1598P/E (TTM)

Allogene Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Allogene Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 13, 2024

Revenue(YoY)

22.00K

-26.67%
EPS(YoY)

-0.38

+44.93%
Analyst Rating

Strong Buy

Jul 22, 2024

Allogene Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 17 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.760K--
--2024/Q2-- / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 12.760K--
--2024/Q2-- / 1.777M--
May 13, 20242024/Q122.000K / 10.430K--
Mar 14, 20242023/Q421.000K / 22.400K--
Nov 2, 20232023/Q343.000K / 9.600K--

Unlock Free Earnings Estimates

Allogene Therapeutics Earnings Reports

  • Allogene Therapeutics | 10-Q: Quarterly report

    May 13 16:07 ET

  • Allogene Therapeutics | 10-K: Annual report

    Mar 14 17:00 ET

  • Allogene Therapeutics | 10-K/A: Annual report (Amendment)

    Mar 14 16:07 ET

  • Allogene Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      81.82%

    • Hold

      18.18%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg